期刊文献+

药物不良事件的防范研究 被引量:18

A Study of the Prevention of Adverse Drug Events in the Cardiovascular Departments
暂未订购
导出
摘要 目的 :探讨心内科病房药物不良事件 (ADE)的防范特征。方法 :由药师深入心内科病房 ,集中监测药物不良事件。主要监测内容是药物不良事件的存在与否 ,可否防范及严重程度。结果 :5个月研究期间共鉴定ADE 64次 ,其中 2 8%可以防范。在重度ADE中 ,50 .0 %可防范 ;在中度ADE中 ,3 3 .3 %可防范 ;在轻度ADE中 ,可防范的比例最少 ,为 13 .6%。结论 :药物不良事件中有相当一部分可以防范 ,而且越是严重的ADE就越有可能被防范。 Objective: To study the prevention of adverse drug events (ADE) in the cardiovascular depar tments.Methods: Pharmacists participated in the clinical drug therapy in the cardiovascular ward s in a tertiary hospital, intensively sur veying ADEs. The main measurements were presence, preventability and severity of an ADE.Result: There were 64 identified ADE, among which 28% were preventable. Of the severe AD Es, 50.0% were preventable; of the moderate ADEs, 33.3% were preventable; of the mild ADEs, 13.6% were preventable. Conclusion: The adverse drug events were common and often preventable in the cardiovascular wards, and the serious ADEs were more likely to be preventable. Some strategies should be taken to prevent ADEs.
出处 《药物流行病学杂志》 CAS 2003年第6期301-303,共3页 Chinese Journal of Pharmacoepidemiology
关键词 药物不良事件 合理用药 心内科病房 心血管疾病 心血管药物 Adverse drug event Prevention Cardiovascular department
  • 相关文献

参考文献12

  • 1[1]Bates DW,Cullen D,Laird N,et al.Incidence of adverse drug event and potential adverse drug events:implication for prevention.JAMA,1995,274:29-34
  • 2[2]Bates DW,Miller EB,Cullen DJ,et al.Patient risk factors for adverse drug events in hospitalized patients.Arch Intern Med,1999,159:2553-2560
  • 3[3]Gurwitz JH,Field TS,Harrold LR,et al.Incidence and preventability of adverse drug events among older persons in the ambulatory setting.JAMA,2003,289:1107-1116
  • 4[4]Naranjo CA,Busto U,Sellers EM,et al.A reliable method for estimating the probability of adverse drug reactions.Clin Phar Ther,1981,30:239-245
  • 5[5]Schumock GT,Thoroton JP.Focusing on preventability of adverse drug reactions.Hosp Pharm,1992,27:538
  • 6[6]Johnson JM,Tanner LA.Postmarketing surveillance:curriculum for the clinical pharmacologist,Part Ⅱ:Clinical and regulatory considerations.J Clin Pharmacol,1993,33:1015-1022
  • 7[7]Gholame K,Shlviri G.Factors associated with preventability,predictability and severity of adverse drug reactions.Ann Pharmacother,1999,33:326-330
  • 8[8]Pearson TF,Pittman DJ,Longley JM,et al.Factors associated with preventable adverse drug reactions.Am J Hosp Pharm,1991,51(18):2268-2272
  • 9[9]Thomas EJ,Brennan TA.Incidence and types of preven-table adverse drug events in elderly patients:population based review of medical records.BMJ,2000,320:741-744
  • 10[10]Bates DW,Spell N,Cullen DJ.The costs of adverse drug events in hospitalized patient.JAMA,1997,277:307-312

同被引文献77

引证文献18

二级引证文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部